Bosniak 2019 分类在光谱 CT 快速千伏切换双能 CT 门静脉期肾肿块分类中的适用性
本研究以 MRI 为参考标准,评估 Bosniak 2019 标准在快速千伏切换双能 CT 门静脉期单期相上对 127 个肾肿块的适用性。结果显示,预设 20 HU 阈值在 ∆HU77keV 上特异性达 88%,但在 ∆HU40keV 上仅 21%;rsDECT 与 MRI 对实性肾肿块和 Bosniak 1 肿块的分类高度一致,但 2 个 Bosniak 2 高密度肾囊肿被误分为实性。作者认为 DECT 有前景,但增强阈值需根据重建类型和虚拟单能级调整。
要点
- 在 rsDECT 门静脉期,区分实性与囊性肾肿块时,预设 20 HU 阈值在 ∆HU77keV 上特异性为 88%,在 ∆HU40keV 上仅 21%。
- rsDECT 与 MRI 对实性肾肿块分类一致率为 92%(23/25),对 Bosniak 1 肿块一致率为 94%(62/66)。
- 2 个 Bosniak 2 高密度肾囊肿在 rsDECT 上被误分为实性肾肿块(2/26,8%)。
核心结论
- DECT 是 Bosniak 分类的有前景工具,尤其有助于区分实性肿块与 Bosniak I-II 囊肿,但已知增强阈值必须根据重建类型尤其是虚拟单能级进行调整。
研究设计与样本
- 研究纳入 127 个在 rsDECT 上评估的肾肿块,以 MRI 为参考标准按 Bosniak 2019 分类。
- 基于门静脉期重建 40、50、77 keV 虚拟单能图像、虚拟平扫(VUE)图像和碘图。
- 计算 VUE 与 40 keV、50 keV、77 keV 测量值之间的衰减变化,分别定义为 ∆HU40keV、∆HU50keV 和 ∆HU77keV。
- 采用约登指数确定检测内部强化的 ∆HU40keV、∆HU50keV 和 ∆HU77keV 最佳诊断性能阈值。
关键影像表现/征象
- 研究人群包括 25 个实性肾肿块(25/127,20%)和 102 个囊性肾肿块(102/127,80%)。
- 为区分实性与囊性肿块,预设 20 HU 阈值在 ∆HU77keV 上特异性为 88%(95%CI:82,93),在 ∆HU40keV 上特异性为 21%(95%CI:15,28)。
- 衰减变化的最佳估计阈值:∆HU77keV 为 19 HU,∆HU50keV 为 69 HU,∆HU40keV 为 111 HU。
- rsDECT 分类与 MRI 对实性肾肿块高度相似(23/25,92%),对 Bosniak 1 肿块高度相似(62/66,94%)。
- 2 个 Bosniak 2 高密度肾肿块(2/26,8%)在 rsDECT 上被分类为实性肾肿块。
诊断标准与关键数值
- 以 MRI 为参考标准,Bosniak 2019 分类用于评估 rsDECT 门静脉期的适用性。
- 检测内部强化:∆HU77keV 最佳阈值 19 HU,∆HU50keV 最佳阈值 69 HU,∆HU40keV 最佳阈值 111 HU。
- 预设 20 HU 阈值区分实性与囊性肿块:∆HU77keV 特异性 88%(95%CI:82,93),∆HU40keV 特异性 21%(95%CI:15,28)。
临床应用与阅片要点
- 在 rsDECT 门静脉期应用 Bosniak 2019 时,需注意增强阈值应随虚拟单能级调整,40 keV 下预设 20 HU 阈值特异性低。
- Bosniak 2 高密度肾囊肿在 rsDECT 上可能模仿实性病变,判读时需结合多参数重建图像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the applicability of Bosniak 2019 criteria on a monophasic portal venous phase using rapid kilovoltage-switching DECT (rsDECT).
MATERIALS AND METHODS: One hundred twenty-seven renal masses assessed on rsDECT were included, classified according to Bosniak 2019 classification using MRI as the reference standard. Using the portal venous phase, virtual monochromatic images at 40, 50, and 77 keV; virtual unenhanced (VUE) images; and iodine map images were reconstructed. Changes in attenuation values between VUE and 40 keV, 50 keV, and 77 keV measurements were computed and respectively defined as ∆HU40keV, ∆HU50keV, and ∆HU77keV. The values of ∆HU40keV, ∆HU50keV, and ∆HU77keV thresholds providing the optimal diagnostic performance for the detection of internal enhancement were determined using Youden index.
RESULTS: Population study included 25 solid renal masses (25/127, 20%) and 102 cystic renal masses (102/127, 80%). To differentiate solid to cystic masses, the specificity of the predefined 20 HU threshold reached 88% (95%CI: 82, 93) using ∆HU77keV and 21% (95%CI: 15, 28) using ∆HU40keV. The estimated optimal threshold of attenuation change was 19 HU on ∆HU77keV, 69 HU on ∆HU50eV, and 111 HU on ∆HU40eV. The rsDECT classification was highly similar to that of MRI for solid renal masses (23/25, 92%) and for Bosniak 1 masses (62/66, 94%). However, 2 hyperattenuating Bosniak 2 renal masses (2/26, 8%) were classified as solid renal masses on rsDECT.
CONCLUSION: DECT is a promising tool for Bosniak classification particularly to differentiate solid from Bosniak I-II cyst. However, known enhancement thresholds must be adapted especially to the energy level of virtual monochromatic reconstructions.
CLINICAL STATEMENT: DECT is a promising tool for Bosniak classification; however, known enhancement thresholds must be adapted according to the types of reconstructions used and especially to the energy level of virtual monochromatic reconstructions.
KEY POINTS: • To differentiate solid to cystic renal masses, predefined 20 HU threshold had a poor specificity using 40 keV virtual monochromatic images. • Most of Bosniak 1 masses according to MRI were also classified as Bosniak 1 on rapid kV-switching dual-energy CT (rsDECT). • Bosniak 2 hyperattenuating renal cysts mimicked solid lesion on rsDECT.
引用
- Reizine E, Blain M, Pescatori L, et al. Applicability of Bosniak 2019 for renal mass classification on portal venous phase at the era of spectral CT imaging using rapid kV-switching dual-energy CT. Eur Radiol. 2023. PMID: 37667141. doi:10.1007/s00330-023-10145-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。